Hemotherapy - hemostasis
Featured publications
-
Endothelial activation and damage associated with steroid-refractory aGVHD are counteracted by ruxolitinib
De Moner, Blanca; Martinez-Sanchez, Julia; Escribano-Serrat, Silvia; Moreno-Casta, Ana Belen; Charry, Paola;(...)Martinez, Carmen; Escolar, Gines; Carreras, Enric; Alvarez-Larra, Alberto; Diaz-Ricart, Maribel.Reference:BLOOD ADVANCES 2026.
-
Comparison of CD34-positive cells enumeration using ADAMII image-based fluorescence cell counter with fluorescence flow cytometry
Cid J; Charry P; Herrera MD; Cardona Í; Soler E;Monfort N; Lozano M.Reference:CLINICAL CHEMISTRY AND LABORATORY MEDICINE 2026.
-
m-EASIX (better than EASIX) predicts severe CAR T-cell toxicities, worse overall survival, and discriminates cytokine release syndrome from sepsis
Moreno-Castano, Ana Belen; Fernandez, Sara; Brillembourg, Helena; Iraola, Gontzal; Moreno, David F;(...)Escolar, Gines; Carreras, Enric; Fernandez-Aviles, Francesc; Castro, Pedro; Diaz-Ricart, Maribel.Reference:Frontiers in Immunology 2026.
-
Proteomic profiling links complement activation to thrombosis in JAK2V617F myeloproliferative neoplasms
De Moner, B; Martinez-Sanchez, J; Escribano-Serrat, S; Ramos, A; Moreno-Castaño, AB;Arellano-Rodrigo, E; Escolar, G; Carreras, E; Alvarez-Larrán, A; Diaz-Ricart, M.Reference:Translational Oncology 2025.
-
Endothelial Damage in JAK2V617F Myeloproliferative Neoplasms with Splanchnic Vein Thrombosis
De Moner, Blanca; Martinez-Sanchez, Julia; Garrote, Marta; Ramos, Alex; Ventosa-Capell, Helena;(...)Garcia-Pagan, Joan Carles; Arellano-Rodrigo, Eduardo; Carreras, Enric; Alvarez-Larran, Alberto; Diaz-Ricart, Maribel.Reference:THROMBOSIS AND HAEMOSTASIS 2025.
-
A survey of cell processing practices for hematopoietic cell transplantation
Fernandez-Sojo, J; Cid, J; Pello, OM; Martínez-Muñoz, ME; Codinach, M;(...)Linares, M; Castillo-Flores, N; Azqueta, C; Valvidia, E; Larrea, L.Reference:CYTOTHERAPY 2025.
-
Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential diagnosis
Moreno-Castaño, AB; Fernández, S; Ventosa, H; Palomo, M; Martinez-Sanchez, J;(...)Escolar, G; Carreras, E; Fernández-Avilés, F; Castro, P; Diaz-Ricart, M.Reference:Journal for ImmunoTherapy of Cancer 2023.
-
Early vascular endothelial complications after hematopoietic cell transplantation: Role of the endotheliopathy in biomarkers and target therapies development
Belen Moreno-Castano, Ana; Queralt Salas, Maria; Palomo, Marta; Martinez-Sanchez, Julia; Rovira, Montserrat;(...)Cid, Joan; Castro, Pedro; Escolar, Gines; Carreras, Enric; Diaz-Ricart, Maribel.Reference:Frontiers in Immunology 2022.
-
Differences and similarities in endothelial and angiogenic profiles of preeclampsia and COVID-19 in pregnancy
Palomo, Marta; Youssef, Lina; Ramos, Alex; Torramade-Moix, Sergi; Belen Moreno-Castano, Ana;(...)Carreras, Enric; Castro, Pedro; Gratacos, Eduard; Crispi, Fatima; Diaz-Ricart, Maribel.Reference:AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 2022.
-
What is going on between defibrotide and endothelial cells? Snapshots reveal the hot spots of their romance
Palomo, Marta; Mir, Enrique; Rovira, Montse; Escolar, Gines; Carreras, Enric;Diaz-Ricart, Maribel.Reference:BLOOD 2016.
